Use of a topical composition containing epidermal growth factor (EGF) for diabetic foot amputation prevention
The present invention is related to the use of topical formulations that contain epidermal growth factor (EGF) encapsulated in or associated to deformable or conventional liposomes to be applied on the surface of and around chronic ischemic skin lesions. The formulations of the present invention, in...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
20.05.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!